Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-31 to 2024-08-01
Current total value of award: $235.6
Description: 4565910132!LORAZEPAM 2 MG/ML VIALML